Latest News about Fold
Recent news which mentions Fold
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
From Benzinga
Billionaire Joe Edelman’s biotech hedge fund hit with SEC charges for not disclosing SPAC conflicts
September 06, 2022
From MarketWatch
From Benzinga
From Benzinga
From Benzinga
This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket
August 03, 2022
From Benzinga
PayPal, SoFi Technologies And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
August 03, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
7 Biotech Stocks With Key Catalysts for May
May 11, 2022
From InvestorPlace
FDA Extends Review Of Amicus Therapeutics' AT-GAA For The Treatment Of Pompe Disease By Three Months
May 10, 2022
Tickers
FOLD
From Benzinga
From Benzinga
Amicus Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 27, 2022
Tickers
FOLD
From Benzinga
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 14, 2022
January 14, 2022
From Benzinga
10 Biggest Price Target Changes For Friday
January 14, 2022
From Benzinga
60 Biggest Movers From Yesterday
January 11, 2022
From Benzinga
From Benzinga
Mid-Day Market Update: Nasdaq Dips 300 Points; Apria Shares Surge
January 10, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.